Sigla Sciences: Your Strategic Partner for Market Access, HEOR, and Med Comms Excellence

At Sigla Sciences, we offer a comprehensive suite of services tailored to meet the needs of pharma, biotech, diagnostics, and health tech companies—from commercialization and market access strategies to specialized “agency-light” communications and creative services. We help clients navigate the complexities of US and European market entry, HEOR, digital engagement, and payer landscapes, with particular expertise in oncology, rare diseases, and specialty therapeutic areas. Though we are a small, agile team, we have a large network of over 200 professionals, including independent experts, boutique firms, and specialized consultants, with decades of experience in bringing leading specialty products to market and navigating complex payer and regulatory requirements. This network allows us to scale our services and provide multidisciplinary expertise, offering the same capabilities and coordination as larger firms—but with extremely competitive pricing. Whether you need HEOR modeling, market access strategy, payer value proposition, NCCN Guideline strategy and submissions, medical communications, or unbranded and branded marketing campaigns, we can seamlessly assemble the right team for your project while maintaining the personalized attention and cost-efficiency that set us apart.

Our focus is on delivering pragmatic solutions that drive product value, enhance market access, and optimize commercialization strategies. Through our lean and agile structure, we combine high-impact strategy with hands-on execution, ensuring your products succeed across the entire value chain.

Our Core Services
1. Market Entry, Market Access, Go To Market, and and HEOR Solutions
-Market Access Strategy: Comprehensive payer engagement frameworks, pricing models, and reimbursement pathways, including HTA submissions (e.g., NICE, ICER), NCCN Guidelines, AMCP Dossiers, pricing market research, Market Access TTP, and billing & coding, particularly for oncology and complex therapies (cell & gene, rare disease)
-HEOR and RWE Analytics: Building robust value propositions using real-world evidence to support payer negotiations and optimize reimbursement strategies. Creating HEOR models and publications that position your product optimally for HTA submissions and US payer acceptance
-US Market Entry Blueprint: Tailored plans to accelerate entry into the US market for emerging US and rest-of-world companies, covering regulatory requirements, payer access strategy, KOL networks for clinical adoption, reimbursement pathways, and billing & coding strategies.

2. Agency-Light Services (Med Comms and Creative Solutions)
We offer agency-light communications services designed to amplify your brand’s voice and connect with key stakeholders:
-Medical Communications (Med Comms): Development of scientific content, KOL engagement strategies, and thought leadership for congresses, publications, and advisory boards.
-Creative Digital Campaigns: Tactical communications to engage HCPs, payers, and patients through traditional and digital channels.
-Brand Messaging and Content Strategy: Alignment of clinical data and evidence with value expectations to build compelling narratives for value dossiers, product launches, and stakeholder outreach.
-Market Access Marketing & Payer Marketing: Unbranded and branded payer and formulary stakeholder communications, payer value proposition, and market access marketing

3. Training and Education Services
Our bespoke training programs empower commercial, medical, and market access teams with the tools needed to excel in dynamic environments, particularly for manufacturers that may be expanding their operations or entering the US or European market for the first time:
-AI and Digital Health Masterclasses: Upskill your teams with advanced training on AI tools for payer engagement, HEOR analytics, and digital market access strategies.
-Payer Strategy Workshops: Customized sessions on market access trends, US reimbursement frameworks, and the evolving payer landscape.
Medical Affairs and Commercial Team Training: Enable cross-functional collaboration through workshops on data-driven decision-making, value messaging, and patient engagement.
-Education on the US market and Market Entry and Market Access for ex-US companies approaching their first US launch or expansion
-Education on the European market for Market Entry and Market Access for companies outside of Europe approaching their first European launch or expansion

Why Choose Sigla Sciences?
-Proven Market Access Expertise: Delivered market access and HEOR solutions for leading oncology and specialty therapies facing pricing pressures and evolving policy frameworks (e.g., IRA policy compliance and MFP effectuation).
-End-to-End Execution: From US market entry planning to payer engagement campaigns and lifecycle management, we ensure your products achieve success at every stage.
-Agility Meets Experience: Our team has 100+ years of combined experience across pharma, biotech, diagnostics, health policy, payer, and digital health startups, enabling us to deliver innovative solutions efficiently.
-Agency-Light Advantage: We combine the strategic rigor of a consultancy with the creative flair of a communications agency, ensuring your message is impactful, targeted, and resonates with stakeholders.

Let’s Collaborate and Drive Success Together
At Sigla Sciences, we don’t just deliver advice—we execute. Whether you need a market access framework, HEOR analytics, creative communications, or US market entry strategy, we offer the solutions and expertise to unlock your product’s potential. Join forces with us to deliver innovative healthcare solutions—from pre-launch strategy through to market expansion and beyond. With our lean structure, deep industry expertise, and agile execution, we’ll help your therapies thrive in the competitive life sciences landscape.